ロード中...
Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells
BACKGROUND: Airway inflammation is a key feature of chronic obstructive pulmonary disease (COPD) and inhaled corticosteroids (ICS) remain the main treatment for airway inflammation. Studies have noted the increased efficacy of ICS and long-acting beta 2 agonist (LABA) combination therapy in controll...
保存先:
| 出版年: | Respir Res |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7901009/ https://ncbi.nlm.nih.gov/pubmed/33622325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01659-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|